Basic Information
NEPHROSTERIL FOR INTRAVENOUS INFUSION
INJECTION
Regulatory Information
SIN06299P
June 21, 1991
General Sale List
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB05BA01
Company Information
Active Ingredients
Strength: 1.9 g/l
Strength: 3.2 g/l
Strength: 1.5 g/l
Strength: 6.2 g/l
Strength: 4.9 g/l
Strength: 4.5 g/l
Strength: 7.1 g/l
Strength: 5.1 g/l
Strength: 2.8 g/l
Strength: 3.8 g/l
Strength: 4.3 g/l
Strength: 4.8 g/l
Strength: 1.38 g/l
Strength: 0.37 g/l
Strength: 6.3 g/l
Strength: 10.3 g/l
Strength: 4.3 g/l
Detailed Information
Contraindications
**Contraindications** Impaired amino acid metabolism, advanced functional impairment of the liver, severe cardiac insufficiency, hyperhydration, hypokalemia, hyponatremia.
Indication Information
**Indications** Balanced supply of protein elements in acute and chronic renal insufficiency as well as during peritoneal and hemodialysis treatment.